Alkermes plc. Increase (Decrease) in Deferred Revenue
Alkermes plc. (ALKS) reported Increase (Decrease) in Deferred Revenue of -$1.45 million for the 12-month period ending 2017-12-31, per its 10-K filed 2018-02-16.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInDeferredRevenue · last filed 2018-02-16
- Alkermes plc. increase (decrease) in deferred revenue for the quarter ending 2017-12-31 was -$345.00K.
- Alkermes plc. increase (decrease) in deferred revenue for the quarter ending 2017-09-30 was -$629.00K, a 258.44% decline year-over-year.
- Alkermes plc. increase (decrease) in deferred revenue for the quarter ending 2017-06-30 was -$368.00K.
- Alkermes plc. increase (decrease) in deferred revenue for the quarter ending 2017-03-31 was -$105.00K.
- Alkermes plc. increase (decrease) in deferred revenue for fiscal 2017 was -$1.45M.
- Alkermes plc. increase (decrease) in deferred revenue for fiscal 2016 was -$649.00K.
- Alkermes plc. increase (decrease) in deferred revenue for fiscal 2015 was -$629.00K.
- Alkermes plc. increase (decrease) in deferred revenue for fiscal 2014 was -$996.00K.
| Period end | Increase (Decrease) in Deferred Revenue 3 month | Increase (Decrease) in Deferred Revenue 6 month | Increase (Decrease) in Deferred Revenue 9 month | Increase (Decrease) in Deferred Revenue 12 month |
|---|---|---|---|---|
| 2017-12-31 | -$345.00K derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-16 | -$974.00K derived: sum of 2 quarters · filed 2018-02-16 | -$1.34M derived: sum of 3 quarters · filed 2018-02-16 | -$1.45M 10-K · filed 2018-02-16 |
| 2017-09-30 | -$629.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2017-10-26 | -$997.00K derived: sum of 2 quarters · filed 2017-10-26 | -$1.10M 10-Q · filed 2017-10-26 | -$1.23M derived: sum of 4 quarters · filed 2018-02-16 |
| 2017-06-30 | -$368.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2017-07-27 | -$473.00K 10-Q · filed 2017-07-27 | -$596.00K derived: sum of 3 quarters · filed 2018-02-16 | -$199.00K derived: sum of 4 quarters · filed 2018-02-16 |
| 2017-03-31 | -$105.00K 10-Q · filed 2017-04-27 | -$228.00K derived: sum of 2 quarters · filed 2018-02-16 | $169.00K derived: sum of 3 quarters · filed 2018-02-16 | -$312.00K derived: sum of 4 quarters · filed 2018-02-16 |
| 2016-12-31 | -$123.00K derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-16 | $274.00K derived: sum of 2 quarters · filed 2018-02-16 | -$207.00K derived: sum of 3 quarters · filed 2018-02-16 | -$649.00K 10-K · filed 2018-02-16 |
| 2016-09-30 | $397.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2017-10-26 | -$84.00K derived: sum of 2 quarters · filed 2017-10-26 | -$526.00K 10-Q · filed 2017-10-26 | $17.00K derived: sum of 4 quarters · filed 2018-02-16 |
| 2016-06-30 | -$481.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2017-07-27 | -$923.00K 10-Q · filed 2017-07-27 | -$380.00K derived: sum of 3 quarters · filed 2018-02-16 | -$764.00K derived: sum of 4 quarters · filed 2018-02-16 |
| 2016-03-31 | -$442.00K 10-Q · filed 2017-04-27 | $101.00K derived: sum of 2 quarters · filed 2018-02-16 | -$283.00K derived: sum of 3 quarters · filed 2018-02-16 | -$743.00K derived: sum of 4 quarters · filed 2018-02-16 |
| 2015-12-31 | $543.00K derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-16 | $159.00K derived: sum of 2 quarters · filed 2018-02-16 | -$301.00K derived: sum of 3 quarters · filed 2018-02-16 | -$629.00K 10-K · filed 2018-02-16 |
| 2015-09-30 | -$384.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-02 | -$844.00K derived: sum of 2 quarters · filed 2016-11-02 | -$1.17M 10-Q · filed 2016-11-02 | -$1.56M derived: sum of 4 quarters · filed 2017-02-17 |
| 2015-06-30 | -$460.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2016-07-28 | -$788.00K 10-Q · filed 2016-07-28 | -$1.18M derived: sum of 3 quarters · filed 2017-02-17 | -$480.00K derived: sum of 4 quarters · filed 2017-02-17 |
| 2015-03-31 | -$328.00K 10-Q · filed 2016-04-28 | -$717.00K derived: sum of 2 quarters · filed 2017-02-17 | -$20.00K derived: sum of 3 quarters · filed 2017-02-17 | -$359.00K derived: sum of 4 quarters · filed 2017-02-17 |
| 2014-12-31 | -$389.00K derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-17 | $308.00K derived: sum of 2 quarters · filed 2017-02-17 | -$31.00K derived: sum of 3 quarters · filed 2017-02-17 | -$996.00K 10-K · filed 2017-02-17 |
| 2014-09-30 | $697.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2015-10-29 | $358.00K derived: sum of 2 quarters · filed 2015-10-29 | -$607.00K 10-Q · filed 2015-10-29 | $2.77M derived: sum of 4 quarters · filed 2016-02-25 |
| 2014-06-30 | -$339.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2015-07-30 | -$1.30M 10-Q · filed 2015-07-30 | $2.08M derived: sum of 3 quarters · filed 2016-02-25 | $2.84M derived: sum of 4 quarters · filed 2016-02-25 |
| 2014-03-31 | -$965.00K 10-Q · filed 2015-04-30 | $2.42M derived: sum of 2 quarters · filed 2016-02-25 | $3.18M derived: sum of 3 quarters · filed 2016-02-25 | $3.09M derived: sum of 4 quarters · filed 2016-02-25 |
| 2013-12-31 | $3.38M derived: 10-K 9 month − 10-Q 6 month · filed 2016-02-25 | $4.15M derived: sum of 2 quarters · filed 2016-02-25 | $4.05M 10-K · filed 2016-02-25 | $3.17M derived: sum of 4 quarters · filed 2016-02-25 |
| 2013-09-30 | $766.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2013-10-31 | $670.00K 10-Q · filed 2013-10-31 | -$208.00K 10-Q · filed 2014-10-29 | -$621.00K derived: sum of 4 quarters · filed 2014-04-30 |
| 2013-06-30 | -$96.00K 10-Q · filed 2013-07-25 | -$974.00K 10-Q · filed 2014-07-31 | -$1.39M derived: sum of 3 quarters · filed 2014-04-30 | -$7.12M derived: sum of 4 quarters · filed 2014-04-30 |
| 2013-03-31 | -$878.00K 10-Q · filed 2014-04-30 | -$1.29M derived: sum of 2 quarters · filed 2014-04-30 | -$7.02M derived: sum of 3 quarters · filed 2014-04-30 | -$3.35M 10-K · filed 2015-02-24 |
| 2012-12-31 | -$413.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2013-01-31 | -$6.14M derived: sum of 2 quarters · filed 2013-10-31 | -$2.47M 10-Q · filed 2013-01-31 | $2.20M derived: sum of 4 quarters · filed 2014-02-27 |
| 2012-09-30 | -$5.73M derived: 10-Q 6 month − 10-Q 3 month · filed 2013-10-31 | -$2.06M 10-Q · filed 2013-10-31 | $2.61M derived: sum of 3 quarters · filed 2014-02-27 | $3.82M derived: sum of 4 quarters · filed 2014-02-27 |
| 2012-06-30 | $3.67M 10-Q · filed 2013-07-25 | $8.34M derived: sum of 2 quarters · filed 2014-02-27 | $9.55M derived: sum of 3 quarters · filed 2014-02-27 | $9.27M derived: sum of 4 quarters · filed 2014-02-27 |
| 2012-03-31 | $4.67M derived: 10-KT 12 month − 10-Q 9 month · filed 2014-02-27 | $5.88M derived: sum of 2 quarters · filed 2014-02-27 | $5.59M derived: sum of 3 quarters · filed 2014-02-27 | $6.07M 10-KT · filed 2014-02-27 |
| 2011-12-31 | $1.21M derived: 10-Q 9 month − 10-Q 6 month · filed 2013-01-31 | $924.00K derived: sum of 2 quarters · filed 2013-01-31 | $1.40M 10-Q · filed 2013-01-31 | $1.03M derived: sum of 4 quarters · filed 2013-05-23 |
| 2011-09-30 | -$285.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2012-11-01 | $189.00K 10-Q · filed 2012-11-01 | -$183.00K derived: sum of 3 quarters · filed 2013-05-23 | -$868.00K derived: sum of 4 quarters · filed 2013-05-23 |
| 2011-06-30 | $474.00K 10-Q · filed 2012-07-26 | $102.00K derived: sum of 2 quarters · filed 2013-05-23 | -$583.00K derived: sum of 3 quarters · filed 2013-05-23 | |
| 2011-03-31 | -$372.00K derived: 10-K 12 month − 10-Q 9 month · filed 2013-05-23 | -$1.06M derived: sum of 2 quarters · filed 2013-05-23 | $635.00K 10-K · filed 2013-05-23 | |
| 2010-12-31 | -$685.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2012-02-02 | $1.01M 10-Q · filed 2012-02-02 | ||
| 2010-09-30 | $1.69M 10-Q · filed 2011-11-03 | |||
| 2010-03-31 | -$4.75M 10-K · filed 2012-05-18 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| RHYTHM PHARMACEUTICALS, INC. (RYTM) | United States | $6.771B | -37.20 |
| IONIS PHARMACEUTICALS INC (IONS) | United States | $7.277B | -23.25 |
| Liquidia Corp (LQDA) | United States | $6.347B | 51.23 |
| Amneal Pharmaceuticals, Inc. (AMRX) | $6.326B | 25.62 | |
| Spyre Therapeutics, Inc. (SYRE) | United States | $7.685B | -43.69 |
| Structure Therapeutics Inc. (GPCR) | United States | $7.710B | -53.41 |
| Praxis Precision Medicines, Inc. (PRAX) | United States | $7.884B | -27.60 |
| Mirum Pharmaceuticals, Inc. (MIRM) | United States | $5.798B | -8.81 |
| Travere Therapeutics, Inc. (TVTX) | United States | $5.712B | -123.10 |
| Oruka Therapeutics, Inc. (ORKA) | United States | $5.663B | -43.76 |